L. Pozzati

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2021, Journal of clinical medicine.

[Hospital study of the incidence of inflammatory bowel disease in the health district of Mérida (Spain)].

L. Pozzati, A. Cabanillas, 2002, Gastroenterologia y hepatologia.

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

J. Gisbert, E. Martí-Bonmatí, X. Calvet, 2017, Journal of Crohn's & colitis.

Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2020, Helicobacter.

European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice

P. Malfertheiner, F. Mégraud, C. O'Morain, 2020, United European gastroenterology journal.

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance.

J. Gisbert, A. Federico, M. Romano, 2013, Gastroenterology.

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain

F. Mégraud, C. O'Morain, J. Gisbert, 2020, Antibiotics.

Su1172 Non-Bismuth Quadruple (Concomitant) Therapy for Eradication of H. pylori: Standard vs. Optimized (14-Day, High-Dose PPI) Regimen

J. Gisbert, L. Rodrigo, J. Barrio, 2014 .